Showing results (601-610 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 13, 2023
Subclinical Celiac Disease Unmasked by Immune Checkpoint Inhibitor TherapyDavid S Braun, Shruti Patel, Armond SchwartzJournal of Immunotherapy (Hagerstown, Md. : 1997)|February 17, 2023
COVID-19: Attacks Immune Cells and Interferences With Antigen Presentation Through MHC-Like Decoy SystemWenzhong Liu, Hualan LiJournal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Large-scale production of natural cytokines during activation and expansion of human T lymphocytes in hollow fiber bioreactor culturesC H Lamers, J W Gratama, B Luider-Vrieling, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Local secretion of IFN-gamma induces an antitumor response: comparison between T cells plus IL-2 and IFN-gamma transfected tumor cellsN Sadanaga, M Nagoshi, J A Lederer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Neuroblastoma cells expressing mature IL-18, but not proIL-18, induce a strong and immediate antitumor immune responseJ G Heuer, C Tucker-McClung, R A HockJournal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
High-resolution HLA-A*0201 subtyping using directed heteroduplex analysisE J Kicklighter, K H Lee, K C Barracchini, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapyS E Alters, J R Gadea, B Holm, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alphaT J Woodlock, D M Sahasrabudhe, D M Marquis, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2L Moltó, J Carballido, L Manzano, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2M Grasso, F Torelli, G Scannapieco, et al.Pageof 176